AcceGen Biotech

04/02/2026

Cell cryopreservation is an essential step in cell research — but it can sometimes introduce variability, even when using standard freezing containers ❄️

That’s why having a ready-to-use solution can really help simplify things in daily lab work.

AcceGen One-Step Freezing Medium is designed to support reliable cell recovery while keeping the workflow straightforward:

❄️ Ready-to-use formulation
📈 Designed to support high post-thaw viability (>90%)*
🧪 Serum-free and protein-free
⚡ No controlled-rate freezing equipment required

Simple 3-step workflow:
1️⃣ Resuspend cells
2️⃣ Aliquot into cryovials
3️⃣ Store directly at -80°C

🎁 Promotion:
• Buy 1 (100 mL) → Get 1 FREE
• Selected tumor or reporter cell lines → Free 50 mL

A simple way to make your workflow smoother and more consistent 🔬

Results may vary depending on cell type and experimental conditions.

10/13/2025

Meet HT-29, a trusted cell model for intestinal and cancer research!

💡 Why scientists choose HT-29:
Mimics the human intestinal barrier
Forms tight junctions and microvilli under differentiation
Works in 2D & 3D cultures
Reliable for drug screening and tumor modeling

From drug absorption studies to colorectal cancer research, HT-29 delivers reproducible and reliable results.

🔬 Discover more: https://www.accegen.com/product/ht-29-abc-tc0428/

10/10/2025

Did you know four tiny glands in your neck are crucial for managing your body's calcium levels? When one goes awry (often from a benign tumor called an adenoma), it can cause a condition called hyperparathyroidism, leading to kidney stones, bone pain, and fatigue.

Treatment typically involves surgery to remove the overactive gland. But behind every medical advancement is dedicated research! AcceGen supports scientists who are working to understand this disease better by providing them with the high-quality cellular tools they need for their studies.

Learn more about the science behind this condition and the research that makes healing possible.
https://www.accegen.com/search/?q=parathyroid

09/29/2025

🌱 Big news in vaccine tech! Researchers from INSERM & King’s College London have shown that just stretching the skin can help deliver vaccines without a needle. Their device uses suction to stretch skin, opening hair follicles and triggering immune responses—even boosting vaccine effectiveness in mice more than traditional injections.

At AcceGen, we’re inspired. Needle-free delivery could mean easier, safer vaccine administration, especially in remote or low-resource settings. It might also open doors for new formats—like patches or lotions—that are gentler and more accessible.

🔗 Discover how AcceGen supports breakthrough biotech research: www.accegen.com

09/29/2025

🔬 Cell Line Spotlight: SH-SY5Y

SH-SY5Y is a human neuroblastoma cell line capable of differentiating into neuron-like cells, making it a valuable tool for neuroscience. Researchers use SH-SY5Y to:

Model Alzheimer’s and Parkinson’s disease

Study neuronal differentiation and development

Evaluate neurotoxicity and neuroprotection

Explore neurotransmitter and signaling pathways

✨ Explore AcceGen’s SH-SY5Y cell line offerings here:
https://www.accegen.com/search/?q=SH-SY5Y

09/25/2025

At AcceGen, we are committed to providing high-quality models that accelerate cancer research.

🔬 NB-4 Cells are a cornerstone for studying acute promyelocytic leukemia (APL), a rare but aggressive form of leukemia. These cells reproduce the hallmark t(15;17) PML-RARA fusion, making them invaluable for:

Understanding APL pathogenesis and progression

Testing differentiation therapies such as ATRA and arsenic trioxide

Investigating drug resistance mechanisms

Exploring transcriptional regulation and hematopoietic differentiation

And the proof is in our customer experience: a client from a leading global biopharmaceutical company shared their feedback the very moment their order arrived:

"Yes, I received the package yesterday. I appreciate your help and support!"

🌟 Trustworthy tools. Reliable service. Real impact.
Learn more: https://www.accegen.com/product/nb-4-abc-tc0725/

NB-4 leukemia cells carry t(15;17) PML-RARα, grow in suspension,RA-sensitive,hypertriploid,and ideal for studying APL differentiation and therapy response.

09/25/2025

Osteoarthritis treatment is moving beyond symptom management to true biological repair. The key? Exosomes 🧬. These tiny messengers are revolutionizing regenerative medicine by targeting the root causes of OA: reducing inflammation and promoting cartilage regeneration.

Discover how AcceGen's high-purity exosomes are powering the next generation of breakthrough therapies. 👇



Explore more: https://www.accegen.com/category/exocome/

09/23/2025

Lab Tip: Immunohistochemistry (IHC)

A key step for reliable IHC is antigen retrieval. Heat or enzymatic treatment exposes epitopes hidden by fixation, making staining clearer and more reproducible.

Explore more resources with AcceGen: www.accegen.com

AcceGen is a US leading biotech company providing various cell products and services for cell and molecular biology. Explore now for scientific research.

09/22/2025

Big strides in neuroscience drug development are underway.

After a pullback from big pharma, the field is seeing invigorated investment—especially around ion channels, which are proving to be powerful, non-opioid targets. Innovations like cryo-EM, organ-on-chip platforms, and AI modeling are helping tackle tough challenges like the blood-brain barrier and patient variability.

AcceGen is proud to support this momentum. We’re leveraging human-centered data analytics, biomarker strategies, and AI tools to help guide the development of safer, more effective brain therapies.

Explore more: www.accegen.com

Let’s work together to reimagine what's possible in neuroscience.

09/22/2025

🔬 Cell Line Spotlight: U937

U937 is a human monocytic cell line established in 1979, widely recognized for its versatility in research. This suspension cell line can be differentiated into macrophage- or dendritic-like cells, making it a robust model for:

🧪 Immunology studies (differentiation, phagocytosis, cytokine secretion)

🧬 Leukemia and oncology research

🔗 Signal transduction pathways (NF-κB, MAPK, JAK/STAT)

💊 Drug screening and toxicology assays

U937 has become a cornerstone in biomedical research, supporting discoveries in immune regulation, cancer biology, and therapeutic development.

✨ Discover AcceGen’s U937 products here:
👉 https://www.accegen.com/search/?q=U937